You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 4, 2024

Loxo Oncol Eli Lilly Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for LOXO ONCOL ELI LILLY, and what generic alternatives to LOXO ONCOL ELI LILLY drugs are available?

LOXO ONCOL ELI LILLY has two approved drugs.

There are five US patents protecting LOXO ONCOL ELI LILLY drugs.

There are one hundred and twenty-two patent family members on LOXO ONCOL ELI LILLY drugs in forty-one countries.

Summary for Loxo Oncol Eli Lilly
International Patents:122
US Patents:5
Tradenames:1
Ingredients:1
NDAs:2

Drugs and US Patents for Loxo Oncol Eli Lilly

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Loxo Oncol Eli Lilly RETEVMO selpercatinib CAPSULE;ORAL 213246-001 May 8, 2020 RX Yes No 10,112,942 ⤷  Sign Up Y Y ⤷  Sign Up
Loxo Oncol Eli Lilly RETEVMO selpercatinib TABLET;ORAL 218160-001 Apr 10, 2024 RX Yes No ⤷  Sign Up ⤷  Sign Up
Loxo Oncol Eli Lilly RETEVMO selpercatinib CAPSULE;ORAL 213246-001 May 8, 2020 RX Yes No ⤷  Sign Up ⤷  Sign Up
Loxo Oncol Eli Lilly RETEVMO selpercatinib CAPSULE;ORAL 213246-001 May 8, 2020 RX Yes No ⤷  Sign Up ⤷  Sign Up
Loxo Oncol Eli Lilly RETEVMO selpercatinib CAPSULE;ORAL 213246-002 May 8, 2020 RX Yes Yes 10,137,124 ⤷  Sign Up ⤷  Sign Up
Loxo Oncol Eli Lilly RETEVMO selpercatinib TABLET;ORAL 218160-002 Apr 10, 2024 RX Yes No 10,137,124 ⤷  Sign Up ⤷  Sign Up
Loxo Oncol Eli Lilly RETEVMO selpercatinib CAPSULE;ORAL 213246-002 May 8, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.